Compounds > losartan

losartan and lercanidipine

losartan has been researched along with lercanidipine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, P; James, IG; Jones, A1
Levi, Z; Rachmani, R; Ravid, M; Zadok, BS1
Huang, CH; Lai, WT; Lin, TH; Sheu, SH; Su, HM; Voon, WC; Yen, HW1
D'Angelo, A; Derosa, G; Franzetti, I; Maffioli, P; Mugellini, A; Pesce, RM; Querci, F1
D'Angelo, A; Derosa, G; Maffioli, P; Mugellini, A; Pesce, RM1

Trials

5 trial(s) available for losartan and lercanidipine

ArticleYear
A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension.
    Journal of human hypertension, 2002, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Severity of Illness Index; Tablets

2002
Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover study.
    Clinical pharmacology and therapeutics, 2002, Volume: 72, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Antihypertensive Agents; Antioxidants; Cross-Over Studies; Diabetes Mellitus, Type 2; Dihydropyridines; Female; Humans; Hypertension; Lipoproteins, LDL; Losartan; Male; Middle Aged; Oxidation-Reduction; Prospective Studies; Single-Blind Method

2002
Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters.
    The Kaohsiung journal of medical sciences, 2006, Volume: 22, Issue:4

    Topics: Antihypertensive Agents; Blood Pressure; Dihydropyridines; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1

2006
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial.
    Scientific reports, 2015, Aug-05, Volume: 5

    Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Nifedipine; Treatment Outcome

2015
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.
    BMC cardiovascular disorders, 2016, Apr-12, Volume: 16

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Italy; Losartan; Male; Middle Aged; Nifedipine; Oxidative Stress; Time Factors; Treatment Outcome

2016